Hunan Hansen Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 443.087 million compared to CNY 311.730 million a year ago. Operating income was CNY 79.837 million compared to CNY 64.709 million a year ago. Net income was CNY 70.635 million compared to CNY 53.230 million a year ago. Basic earnings per share from continuing operations was CNY 0.1404 compared to CNY 0.1058 a year ago.